Biomarker Identification
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Interpretable Graph Kolmogorov-Arnold Networks for Multi-Cancer Classification and Biomarker Identification using Multi-Omics Data
arXiv:2503.22939v4 Announce Type: replace Abstract: The integration of heterogeneous multi-omics datasets at a systems level remains a central challenge for developing analytical and computational models in precision cancer diagnostics. This paper introduces Multi-Omics Graph Kolmogorov-Arnold Network (MOGKAN), a deep learning framework that utilizes messenger-RNA, micro-RNA sequences, and DNA methylation samples together with Protein-Protein Interaction (PPI) networks for cancer...
Temporal Biodynamics: An AI Platform for Identification of Stage-Relevant Targets and Biomarkers
Temporal modeling of disease progression is poised to revolutionize the process of target identification, leading to better characterization of and intervention at the critical early stages of chronic conditions. Temporal Biodynamics is an artificial intelligence-driven platform that leverages within-tissue heterogeneity in cross-sectional cohorts to assemble a single, continuous trajectory of transcriptomic changes between health and disease. We demonstrate that the platform enriches for...
Light-induced quantum friction of carbon nanotubes in water
Abstract Friction slows down moving objects at both macroscopic and microscopic scales1. At the electronic level, quantum friction describes direct transfer of momentum between a liquid and the electrons of a solid2. Owing to its microscopic nature, this phenomenon remains experimentally challenging to capture3.
Advancements in Machine Learning and Deep Learning for Early Detection and Management of Mental Health Disorder
arXiv:2412.06147v2 Announce Type: replace Abstract: For the early identification, diagnosis, and treatment of mental health illnesses, the integration of deep learning (DL) and machine learning (ML) have started playing a significant role. By evaluating complex data from imaging, genetics, and behavioral assessments, these technologies have the potential to improve clinical results significantly. However, they also present unique challenges relating to data integration and ethical issues.
A prognostic human brain network for diffuse midline glioma
Abstract Diffuse midline gliomas (DMGs) are near-universally lethal tumours of the childhood central nervous system1,2. In animal models, DMGs form brain-wide integrated networks through neuron-to-glioma synapses3,4,5,6 and glioma-to-glioma gap junctional coupling3. This extensive connectivity robustly promotes the growth and invasion of DMG3,4,5,6,7,8,9 and other glial malignancies10,11,12 through paracrine mechanisms and direct neuron-to-glioma synapses.